Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blood-brain barrier and DNA changes during the evolution of experimental allergic encephalomyelitis.

× No keyword cloud information.

10 in total

Review 1. Quantitative aspects of reactive gliosis: a review.

Authors: W T Norton; D A Aquino; I Hozumi; F C Chiu; C F Brosnan
Journal: Neurochem Res Date: 1992-09 Impact factor: 3.996

2. Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.

Authors: Sheila R Plant; Ying Wang; Sophie Vasseur; J Cameron Thrash; Eileen J McMahon; Daniel T Bergstralh; Heather A Arnett; Stephen D Miller; Monica J Carson; Juan L Iovanna; Jenny P-Y Ting
Journal: Glia Date: 2006-04-01 Impact factor: 7.452

3. The clotting system: gatekeeper of cerebrovascular permeability and monitor of clinical manifestations of neuroautoimmune disease.

Authors: P Y Paterson; J Gausas; C S Koh; H C Kwaan
Journal: Trans Am Clin Climatol Assoc Date: 1986

4. Localization of toxic encephalopathies near lesions of experimental allergic encephalomyelitis.

Authors: S Levine; R Sowinski
Journal: Am J Pathol Date: 1982-05 Impact factor: 4.307

5. Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy.

Authors: James R Tonra
Journal: Cerebellum Date: 2002 Jan-Mar Impact factor: 3.847

6. Fluorescein labelled dextrans as tracers for vascular permeability studies in the nervous system.

Authors: Y Olsson; E Svensjö; K E Arfors; D Hultström
Journal: Acta Neuropathol Date: 1975-10-27 Impact factor: 17.088

7. About demyelinating properties of humoral antibodies in experimental allergic encephalomyelitis. In vivo and in vitro studies.

Authors: K Kristensson
Journal: Acta Neuropathol Date: 1976-12-21 Impact factor: 17.088

8. High Speed Ventral Plane Videography as a Convenient Tool to Quantify Motor Deficits during Pre-Clinical Experimental Autoimmune Encephalomyelitis.

Authors: Jiangshan Zhan; Vladislav Yakimov; Sebastian Rühling; Felix Fischbach; Elena Nikolova; Sarah Joost; Hannes Kaddatz; Theresa Greiner; Julia Frenz; Carsten Holzmann; Markus Kipp
Journal: Cells Date: 2019-11-14 Impact factor: 6.600

9. Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.

Authors: Magdalena Polanczyk; Srikanth Yellayi; Alex Zamora; Sandhya Subramanian; Micah Tovey; Arthur A Vandenbark; Halina Offner; James F Zachary; Parley D Fillmore; Elizabeth P Blankenhorn; Jan-Ake Gustafsson; Cory Teuscher
Journal: Am J Pathol Date: 2004-06 Impact factor: 4.307

10. Neurovascular damage in experimental allergic encephalomyelitis: a target for pharmacological control.

Authors: C Bolton
Journal: Mediators Inflamm Date: 1997 Impact factor: 4.711

10 in total